FDA proposes removal of oral Phenylephrine from OTC nasal decongestant products
Agency cites lack of effectiveness as basis for proposed change, allowing continued sales pending final order
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.